Plain-English translation of NCT07536087 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA), a procedure that uses heat to destroy certain pancreatic growths. The treatment is delivered through a thin tube passed down the throat, allowing doctors to see the pancreas with ultrasound and apply heat directly to abnormal tissue. This approach may offer a less invasive option for patients with pancreatic cysts or neuroendocrine tumors who cannot have or prefer not to have traditional surgery.
Pancreatic cysts and tumors are increasingly being found on imaging scans, but deciding how to treat them is challenging. Many patients are unsuitable for or reluctant to undergo major surgery. This trial exists to determine whether heat treatment delivered through an endoscope can safely and effectively destroy these growths while avoiding the risks and recovery time of surgical removal.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive the heat treatment procedure, which involves passing a thin tube with an ultrasound camera and heat device down your throat to reach the pancreas. The procedure is typically done under sedation. Your medical team will monitor you during and after the treatment, and you will likely have follow-up imaging and visits to ensure the treatment worked and to watch for any side effects. The exact timeline and number of visits will depend on your individual situation and how your pancreas responds to treatment.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Czechia